Fortress Biotech, Inc. Balance Sheet
FBIO|11 years of annual SEC 10-K data (FY2015-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 11 fiscal years. All figures from audited SEC 10-K filings.
Fortress Biotech, Inc. had $186M in total assets and $50M in shareholders' equity as of FY2025. Total debt was $52M against $79M in cash, resulting in a $27M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $79.4M | $57.3M | $80.9M | $178.3M | $305.7M | $136.9M | $136.9M | $65.5M | $88.3M | $98.2M | $99.5M |
| Accounts Receivable | $29.8M | $10.2M | $15.2M | $28.2M | $23.1M | $13.5M | $13.5M | $5.5M | $7.8M | $1.8M | - |
| Inventory | $9.6M | $14.4M | $10.2M | $14.2M | $9.9M | $857.0K | $857.0K | $678.0K | $171.0K | $203.0K | - |
| Current Assets | $123.8M | $90.4M | $117.0M | $230.4M | $346.5M | $156.3M | $156.3M | $111.2M | $183.2M | $109.6M | $99.8M |
| PP&E (Net) | $2.5M | $3.3M | $6.5M | $13.0M | $15.1M | $12.4M | $12.4M | $12.0M | $2.4M | $1.2M | $309.0K |
| Goodwill | - | - | - | - | - | - | - | - | $18.6M | $18.6M | - |
| Total Assets | $185.5M | $144.2M | $167.5M | $294.3M | $396.5M | $226.4M | $226.4M | $141.0M | $245.9M | $118.6M | $118.6M |
| Current Liabilities | $49.7M | $71.4M | $84.9M | $127.7M | $101.0M | $45.6M | $45.6M | $55.6M | $67.4M | $56.6M | $10.6M |
| Total Debt | $52.4M | $58.0M | $60.9M | $91.7M | $42.9M | $84.7M | $89.7M | $84.4M | $67.5M | $30.2M | $24.0M |
| Shareholders' Equity | $49.9M | $22.7M | $22.5M | $41.7M | $108.7M | $26.2M | $26.2M | $1.9M | $52.6M | $38.5M | $56.8M |